샘플 요청 목록

 카트 문의
시장보고서
상품코드
1656910

낭포성 섬유증용 기도 확보 장치 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(-2032년)

Airway Clearance Devices for Cystic Fibrosis - Market Insights, Competitive Landscape, and Market Forecast - 2032
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

낭포성 섬유증용 기도 확보 장치 시장 규모는 예측 기간 동안 5.03%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

낭포성 섬유증용 기도 확보 장치 수요는 낭포성 섬유증 유병률 증가, 유전성 질환 사례 증가, 연구개발 활동 증가, 주요 기업 간 연구 협력 등에 의해 촉진되고 있습니다.

낭포성 섬유증용 기도 확보 장치 시장 역학:

2023년 1월 영국 의회가 발표한 보고서에 따르면 2023년 영국에서 약 1,800명이 낭포성 섬유증을 앓고 있으며, 2024년 5월 Vertex Pharmaceuticals Incorporated의 발표에 따르면 전 세계적으로 9만 2,000명이 낭포성 섬유증 진단을 받은 것으로 추정됩니다. 낭포성 섬유증 진단을 받은 것으로 추정되고 있습니다. 기도 확보 장치는 기도 벽을 깨끗하게 하여 낭포성 섬유증 관리에 도움이 되기 때문에 낭포성 섬유증 유병률 증가는 시장 성장을 가속할 것으로 예상됩니다.

시장의 주요 기업들은 병원 및 재택치료용 기도 확보 장치의 개발 및 상용화에 주력하고 있습니다. 주요 기업들의 연구개발 활동이 활발해지면서 낭포성 섬유증용 기도확보장치 시장의 성장을 견인하고 있습니다.

장치 유형별로는 고주파 흉벽 진동 장치 부문이 2024년 가장 큰 매출 점유율을 차지할 것으로 추정됩니다. 고주파 흉벽 진동 장치는 흉벽의 기계적 진동 또는 진동을 이용하여 기도에 축적된 점액의 배출을 돕고 점액의 이완과 동원을 촉진합니다. 이 장치는 기도 벽에서 가래와 점액을 제거해야 하는 만성 폐 질환의 치료에도 사용됩니다.

지역별로는 북미가 2024년 압도적인 시장 점유율을 보일 것으로 예상됩니다. 이는 이 지역에서 낭포성 섬유증의 유병률이 증가하고 있기 때문입니다.

세계의 낭포성 섬유증용 기도 확보 장치 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 및 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 낭포성 섬유증용 기도 확보 장치 시장 보고서 : 서론

  • 조사 범위
  • 시장 세분화
  • 시장 전제 요인

제2장 낭포성 섬유증용 기도 확보 장치 시장 : 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 낭포성 섬유증용 기도 확보 장치 시장 : 주요 요인 분석

  • 시장 성장 촉진요인
  • 시장 성장 억제요인과 과제
  • 시장 기회

제6장 낭포성 섬유증용 기도 확보 장치 시장 : Porter의 Five Forces 분석

제7장 낭포성 섬유증용 기도 확보 장치 시장 평가

  • 디바이스 유형별
    • 고주파 흉벽 진동 디바이스
    • 호기양압 디바이스
    • 메커니컬 퍼크션(MP) 디바이스
    • 기타
  • 최종사용자별
    • 병원 및 진료소
    • 재택치료
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 낭포성 섬유증용 기도 확보 장치 시장 : 기업 및 제품 개요

  • Baxter
  • Koninklijke Philips N.V.
  • Electromed, Inc.
  • ICU Medical, Inc.
  • Trudell Medical International
  • CEGLA Medizintechnik GmbH
  • PARI GmbH
  • Monaghan
  • VORTRAN Medical Technology 1 Inc.
  • Tactile Medical
  • Mercury Medical
  • Med Systems, Inc.
  • Vyaire Medical, Inc.
  • Synchrony Medical
  • Dymedso
  • SunMed LLCWestmed, Inc.
  • RespInnovation
  • Inogen, Inc.
  • Thayer Medical
  • Medline Industries, LP

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항 및 문의

LSH 25.03.06

Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of cystic fibrosis and respiratory disorders and rising incidence of genetic diseases

The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032. The demand for airway clearance devices for cystic fibrosis is primarily driven by the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, and research collaboration among key players are some of the key factors responsible for contributing to the positive growth of airway clearance devices for the cystic fibrosis market during the forecast period from 2025 to 2032.

Airway Clearance Devices for Cystic Fibrosis Market Dynamics:

The airway clearance devices are created based on physiological principles that work by creating resistance and vibration that help to loosen and clear mucous from airway walls to enhance sputum clearance. According to a report published by the UK Parliament in January 2023, stated that approximately 10,800 people were living with cystic fibrosis in 2023 in the United Kingdom. According to Vertex Pharmaceuticals Incorporated in May 2024, it was estimated that 92,000 people were diagnosed with cystic fibrosis across the globe. Airway clearance devices help to manage cystic fibrosis by clearing the airway walls, thus, the rising prevalence of cystic fibrosis is expected to drive the market growth.

Cystic fibrosis is a genetic condition caused by gene abnormality that causes the production of abnormally thick and sticky liquid called mucous. According to NHS England in February 2024, approximately 3.5 million people were affected by genetic diseases in 2021 in the United Kingdom and this number comprises 1 in 17 people being affected by a rare disease. Therefore, the rising occurrence of rare genetic diseases contributes to increased cases of cystic fibrosis which is contributing to the growth of the market.

Key players in the market are concentrating their efforts on developing and commercializing airway clearance devices for hospital and home healthcare applications. For instance, in December 2022, ABM Respiratory Care announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the BiWaze(R) Clear System. This airway clearance system helps patients clear their airways as well as prevent or treat cystic fibrosis by using oscillating lung expansion (OLE) therapy. Therefore, the increasing research and development activities by key players are driving the growth of airway clearance devices for the cystic fibrosis market.

However, the complications associated with airway clearance devices, and product recalls, among others are some of the key constraints that may hinder the growth of airway clearance devices for the cystic fibrosis market.

Airway Clearance Devices for Cystic Fibrosis Market Segment Analysis:

Airway Clearance Devices for Cystic Fibrosis Market by Device Type (High-Frequency Chest Wall Oscillation Device, Positive Expiratory Pressure Devices, Mechanical Percussion (MP) Devices, and Others), End-User (Hospitals & Clinics, Home Healthcare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of airway clearance devices for the cystic fibrosis market, the high-frequency chest wall oscillation device category is estimated to hold the largest revenue share in the airway clearance devices for the cystic fibrosis market in 2024. High-frequency chest wall oscillation devices use mechanical oscillations or vibrations on the chest wall to aid in the clearance of accumulated mucus from the airways, facilitating its loosening and mobilization. This device is also used for the treatment of chronic lung diseases which require clearance of sputum and mucous from airway walls.

Key players in the market are developing advanced devices for the management of cystic fibrosis and other disease that require devices for airway clearances. For instance, in November 2022, Electromed, Inc. announced that it received U.S Food and Drug Administration 510(k) clearance for the SmartVest(R) Clearway(R) Airway Clearance System, which is designed for High-Frequency Chest Wall Oscillation therapy. This device works by delivering alternating pulses of air into a vest, causing rapid compression and release of the chest wall. This process generates airflow oscillations within the airways, which serve to loosen, thin, and propel mucus towards the larger airways for easier expectoration.

Therefore, the growing use of high-frequency chest wall oscillation devices in cystic fibrosis is expected to contribute to the growth of the segment, thereby driving the growth of the airway clearance devices for the cystic fibrosis market during the forecast period.

North America is expected to dominate the overall Airway Clearance Devices for Cystic Fibrosis Market:

North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. The rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.

Air clearance devices mechanically conducts chest physical therapy through high-frequency vibrations. The vest vibrates the chest to help loosen and thin thick, sticky mucus commonly found in cystic fibrosis. According to data published by Centers for Disease Control and Prevention (CDC) in May 2024, approximately 35,000 peoples were suffering with cystic fibrosis in 2024 in the United States. Therefore, the rising cases of cystic fibrosis is expected to drive the market growth in North America.

Airway Clearance Devices for Cystic Fibrosis Market Key Players:

Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.

Recent Developmental Activities in the Airway Clearance Devices for Cystic Fibrosis Market:

  • In September 2023, Inogen, Inc. completed the acquisition of Physio-Assist SAS. Through this acquisition, Inogen acquired Simeox from Physio-Assist which is a technology-enabled airway clearance and mucus management device for treatment of cystic fibrosis.
  • In September 2021, Tactile Medical completed acquisition of AffloVest respiratory therapy business from International Biophysics Corporation. This acquisition strengthened the position of Tactile Medical in cystic fibrosis treatment market and increased its product portfolio and global presence.

Key Takeaways from the Airway Clearance Devices for Cystic Fibrosis Market Report Study

  • Market size analysis for current Airway Clearance Devices For Cystic Fibrosis Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Airway Clearance Devices for Cystic Fibrosis market.
  • Various opportunities available for the other competitors in the Airway Clearance Devices for Cystic Fibrosis Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Airway Clearance Devices for Cystic Fibrosis market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Airway Clearance Devices for Cystic Fibrosis market growth in the coming future?

Target Audience who can be benefited from this Airway Clearance Devices for Cystic Fibrosis Market Report Study

  • Airway Clearance Devices For Cystic Fibrosis product providers
  • Research organizations and consulting companies
  • Airway Clearance Devices For Cystic Fibrosis related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Airway Clearance Devices For Cystic Fibrosis
  • Various end-users who want to know more about the Airway Clearance Devices for Cystic Fibrosis Market and the latest technological developments in the Airway Clearance Devices for Cystic Fibrosis Market.

Frequently Asked Questions for the Airway Clearance Devices for Cystic Fibrosis Market:

1. What are Airway Clearance Devices for Cystic Fibrosis?

  • Airway clearance devices for cystic fibrosis are specialized devices that mechanically aid in clearing thick, sticky mucus from the airways, thereby enhancing lung function and improving airways wall clearance.

2. What is the market for Airway Clearance Devices for Cystic Fibrosis?

  • The airway clearance devices for cystic fibrosis market is estimated to grow at a CAGR of 5.03% during the forecast period from 2025 to 2032.

3. What are the drivers for the global Airway Clearance Devices for Cystic Fibrosis market?

  • The airway clearance devices for cystic fibrosis market is slated to witness prosperity owing to factors such as the growing prevalence of cystic fibrosis, increasing genetic disease cases, growing R&D activities, research collaborations among key players are some of the key factors responsible for contributing to the positive growth of the airway clearance devices for cystic fibrosis market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global Airway Clearance Devices for Cystic Fibrosis market?

  • Some of the key market players operating in the airway clearance devices for cystic fibrosis market include Baxter, Koninklijke Philips N.V., Electromed, Inc., ICU Medical, Inc., Trudell Medical International, CEGLA Medizintechnik GmbH, PARI GmbH, Monaghan, VORTRAN Medical Technology 1 Inc., Tactile Medical, Mercury Medical, Med Systems, Inc., Vyaire Medical, Inc., Synchrony Medical, Dymedso, SunMed LLCWestmed, Inc., RespInnovation, Inogen, Inc., Thayer Medical, Medline Industries, LP, and others.

5. Which region has the highest share in the global Airway Clearance Devices For Cystic Fibrosis market?

  • North America is expected to hold dominate market share in the airway clearance devices for cystic fibrosis market in 2024. This is due to the growing prevalence of cystic fibrosis in the region. Thus the rising number of people suffering from cystic fibrosis requiring airway clearance devices to manage disease conditions in the region is a key factor driving the growth of the North America airway clearance devices for cystic fibrosis market.

Table of Contents

1. Airway Clearance Devices For Cystic Fibrosis Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Airway Clearance Devices For Cystic Fibrosis Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Airway Clearance Devices For Cystic Fibrosis Market Key Factors Analysis

  • 5.1. Airway Clearance Devices For Cystic Fibrosis Market Drivers
    • 5.1.1. The growing prevalence of cystic fibrosis
    • 5.1.2. Increasing genetic disease cases
    • 5.1.3. Growing R&D activities and research collaboration among key players
  • 5.2. Airway Clearance Devices For Cystic Fibrosis Market Restraints and Challenges
    • 5.2.1. Complications associated with airway clearance devices
    • 5.2.2. Product recalls
  • 5.3. Airway Clearance Devices For Cystic Fibrosis Market Opportunity
    • 5.3.1. Integration of digital health for homecare settings
    • 5.3.2. Emergence of AI-enabled airway clearance devices

6. Airway Clearance Devices For Cystic Fibrosis Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Airway Clearance Devices For Cystic Fibrosis Market Assessment

  • 7.1. By Device Type
    • 7.1.1. High Frequency Chest Wall Oscillation Device
    • 7.1.2. Positive Expiratory Pressure Devices
    • 7.1.3. Mechanical Percussion (MP) Devices
    • 7.1.4. Others
  • 7.2. By End-User
    • 7.2.1. Hospitals and Clinics
    • 7.2.2. Home Healthcare
    • 7.2.3. Others
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.1.2. Canada Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.1.3. Mexico Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.2. Europe
      • 7.3.2.1. France Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.2.2. Germany Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.2.3. United Kingdom Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.2.4. Italy Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.2.5. Spain Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.2.6. Rest of Europe Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.3.2. Japan Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.3.3. India Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.3.4. Australia Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.3.5. South Korea Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.3.6. Rest of Asia-Pacific Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.4.2. Africa Airway Clearance Devices For Cystic Fibrosis Market Size in USD million (2022-2032)
      • 7.3.4.3. South America Airway Clearance Devices For Cystic Fibrosis Market Size In USD Million (2022-2032)

8. Airway Clearance Devices For Cystic Fibrosis Market Company and Product Profiles

  • 8.1. Baxter
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Koninklijke Philips N.V.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Electromed, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ICU Medical, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Trudell Medical International
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. CEGLA Medizintechnik GmbH
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. PARI GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Monaghan
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. VORTRAN Medical Technology 1 Inc.
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Tactile Medical
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Mercury Medical
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Med Systems, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Vyaire Medical, Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Synchrony Medical
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Dymedso
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. SunMed LLCWestmed, Inc.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. RespInnovation
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Inogen, Inc.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Thayer Medical
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Medline Industries, LP
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제